 Eli Lilly Co. NYSE: LLY expressed plans of acquiring Prevail Therapeutics Inc. NASDAQ: PRVL on Tuesday for 770 million a move that it says will help it expand its footprint in gene therapy. Lilly announced a 15 increase in quarterly dividend earlier this week. 